Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,988 DKK | -0.77% | -3.69% | -7.89% |
05-03 | GENMAB : A good start to 2024; guidance unchanged | |
05-03 | Genmab Posts Q1 Net Profit Surge; Revenue Jumps | MT |
Sales 2024 * | 19.8B 2.86B 3.91B | Sales 2025 * | 23.62B 3.42B 4.67B | Capitalization | 129B 18.71B 25.57B |
---|---|---|---|---|---|
Net income 2024 * | 4.68B 677M 926M | Net income 2025 * | 6.63B 959M 1.31B | EV / Sales 2024 * | 5.17 x |
Net cash position 2024 * | 27.03B 3.91B 5.34B | Net cash position 2025 * | 32.17B 4.65B 6.36B | EV / Sales 2025 * | 4.12 x |
P/E ratio 2024 * |
29.4
x | P/E ratio 2025 * |
21.1
x | Employees | 2,286 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.51% |
Latest transcript on Genmab A/S
1 day | -0.77% | ||
1 week | -3.69% | ||
Current month | +1.46% | ||
1 month | -4.84% | ||
3 months | +4.04% | ||
6 months | -7.80% | ||
Current year | -7.89% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 98-12-31 | |
Anthony Pagano
DFI | Director of Finance/CFO | 46 | 06-12-31 |
Anthony Mancini
COO | Chief Operating Officer | 53 | 20-03-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Deirdre Connelly
CHM | Chairman | 63 | 16-12-31 |
Director/Board Member | 73 | 03-10-31 | |
Rolf K. Hoffmann
BRD | Director/Board Member | 64 | 15-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.64% | 200 M€ | +17.40% | ||
1.28% | 48 M€ | +9.09% | ||
1.01% | 85 M€ | +0.69% | ||
0.75% | 17 M€ | +6.60% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 1,985 | -0.90% | 48 826 |
24-05-08 | 2,003 | -0.45% | 98,861 |
24-05-07 | 2,012 | +0.40% | 98,188 |
24-05-06 | 2,004 | -2.77% | 103,761 |
Delayed Quote Nasdaq Copenhagen, May 13, 2024 at 08:12 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.89% | 18.68B | |
+3.91% | 109B | |
+10.87% | 105B | |
+0.12% | 22.25B | |
-13.14% | 22.09B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B | |
+295.70% | 8.12B |
- Stock Market
- Equities
- GMAB Stock